We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

71 hedge funds and large institutions have $305M invested in Collegium Pharmaceutical in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 15

76% more capital invested

Capital invested by funds: $173M → $305M (+$132M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 73 → 71 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

94% less call options, than puts

Call options by funds: $58K | Put options by funds: $963K

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
27
Reduced
15
Closed
10
Calls
$58K
Puts
$963K
Net Calls
-$905K
Net Calls Change
-$910K

Top Buyers

1
CCM
Cadian Capital Management
New York
+$5.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$4.89M
3
PHS
PFM Health Sciences
California
+$4.78M
4
RSCM
Rock Springs Capital Management
Maryland
+$3.92M
5
HCMT
Highland Capital Management (Texas)
Texas
+$1.96M

Top Sellers

1
EC
EcoR1 Capital
California
-$3.34M
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.63M
3
AII
AGF Investments Inc
Ontario, Canada
-$1.32M
4
SM
Sabby Management
Florida
-$1.2M
5
TA
Tamarack Advisers
California
-$1.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$38.7M +$713K +60,002 +3%
FM
2
Frazier Management
Washington
$36.4M – – –
RSCM
3
Rock Springs Capital Management
Maryland
$29.8M +$3.92M +330,000 +27%
HM
4
HealthCor Management
New York
$27M +$891K +75,000 +6%
TGHSA
5
TPG Group Holdings (SBS) Advisors
Texas
$26.8M – – –
Franklin Resources
6
Franklin Resources
California
$17.5M +$40.8K +3,432 +0.4%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$14.7M -$479K -40,300 -5%
SAM
8
Sectoral Asset Management
Quebec, Canada
$13.6M +$4.89M +411,445 +140%
BFA
9
BlackRock Fund Advisors
California
$13.4M +$518K +43,581 +7%
Vanguard Group
10
Vanguard Group
Pennsylvania
$10.1M +$437K +36,779 +8%
Massachusetts Financial Services
11
Massachusetts Financial Services
Massachusetts
$9.8M +$103K +8,686 +2%
CCM
12
Cadian Capital Management
New York
$9.25M +$5.7M +480,141 New
CAM
13
Cormorant Asset Management
Massachusetts
$8.77M – – –
PHS
14
PFM Health Sciences
California
$7.75M +$4.78M +402,446 New
HCMT
15
Highland Capital Management (Texas)
Texas
$6.29M +$1.96M +164,875 +102%
BIT
16
BlackRock Institutional Trust
California
$5.03M – – –
State Street
17
State Street
Massachusetts
$3.81M +$249K +20,935 +12%
Northern Trust
18
Northern Trust
Illinois
$3.4M +$60.3K +5,079 +3%
LPL Financial
19
LPL Financial
California
$2.4M +$275K +23,173 +24%
Deutsche Bank
20
Deutsche Bank
Germany
$2.38M +$664K +55,931 +83%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.03M +$239K +20,148 +24%
JGC
22
J. Goldman & Co
New York
$1.5M -$249K -21,000 -21%
RJA
23
Raymond James & Associates
Florida
$1.39M +$38.2K +3,220 +5%
NC
24
NBW Capital
Massachusetts
$1.19M -$4.12K -347 -0.6%
BCMNY
25
Buckingham Capital Management (New York)
New York
$1.03M +$633K +53,300 New
1
2 3 4

COLL Hedge Fund Activity: Q3 2016 in Review

71 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2016, worth a combined $305M — up 76% from $173M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of COLL and 8 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 27 added.

The largest buyer was Cadian Capital Management, opening a new position worth an estimated $5.7M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.34M sold.

  • 71 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $305M of Collegium Pharmaceutical stock for Q3 2016, up 76% quarter-over-quarter.
  • 8 funds opened new Collegium Pharmaceutical positions in Q3 2016 and 10 closed out, a net change of -2 holders.
  • The largest Collegium Pharmaceutical buyer in Q3 2016 was Cadian Capital Management, an estimated $5.7M added.
  • The largest Collegium Pharmaceutical seller in Q3 2016 was EcoR1 Capital, an estimated $3.34M sold.

Based on aggregated 13F filings for Q3 2016.